Daniel J. Rubin
Temple University
42 Papers
57 Citations
Daniel J. Rubin is an academic researcher from Temple University. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 14, co-authored 33 publications. Previous affiliations of Daniel J. Rubin include Boston University.
Chat about Author
Papers
Hospital readmission of patients with diabetes.
TL;DR: In this paper, the authors focused on patients with diabetes and found that those with diabetes may be at higher risk of readmission than those without diabetes, and proposed to reduce readmission risk by inpatient education, specialty care, better discharge instructions, coordination of care and post-discharge support.
157
Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial
Francisco J. Pasquel,Roma Y. Gianchandani,Daniel J. Rubin,Kathleen Dungan,Isabel Anzola,Patricia C. Gomez,Limin Peng,Israel Hodish,Tim W. Bodnar,David H. Wesorick,Vijay Balakrishnan,Kwame Osei,Guillermo E. Umpierrez +12 more
TL;DR: Treatment with sitagliptin plus basal insulin is as effective and safe as, and a convenient alternative to, the labour-intensive basal-bolus insulin regimen for the management of hyperglycaemia in patients with type 2 diabetes in general medicine and surgery in hospitals.
155
Consensus Statement on Inpatient Use of Continuous Glucose Monitoring.
Amisha Wallia,Guillermo E. Umpierrez,Robert J. Rushakoff,David C. Klonoff,Daniel J. Rubin,Sherita Hill Golden,Curtiss B. Cook,Curtiss B. Cook,Bithika Thompson +8 more
TL;DR: Panel members agreed that data from limited studies and theoretical considerations suggested that use of CGM in the hospital had the potential to improve patient clinical outcomes, and in particular reduction of hypoglycemia.
126
Weight-Based, Insulin Dose–Related Hypoglycemia in Hospitalized Patients With Diabetes
TL;DR: In this article, the association of weight-based insulin dose with hypoglycemia in noncritically ill inpatients with diabetes was determined by a case-control study of 1,990 diabetic patients admitted to hospital wards.
85
Early readmission among patients with diabetes: a qualitative assessment of contributing factors.
TL;DR: Several interventions are suggested that may reduce the risk of early readmission for patients with diabetes, including inpatient diabetes education, improving communication of discharge instructions, and involving patients more in medication reconciliation and post-discharge planning.
83